BAY 11-7082 protects rats from DN by reducing the expression of inflammatory cytokines including TNF-α, IL-1β, and IL-6, and inhibiting the oxidative damage mediated by hyperglycemia (Kolati et al., 2015). The gene discussed is IL6; the disease is Hyperglycemia.